111, Inc.
YI Nasdaq Retail-Drug Stores And Proprietary Stores Financials FY2016โFY2025
What 111, Inc. does
No business description yet.
- Legal name
- 111, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Apr 30, 2026
- Accession ยท CIK
- 0001104659-26-052002
0001738906
Revenue and margins
111, Inc. had $1.7B of revenue in fiscal 2025, down 12.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $16.0M in fiscal 2025, 0.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
111, Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 1.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably 111, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $133M | $127M | $92.0M | $63.3M | $80.1M |
| Debt incl. finance leases | $40.9M | $25.9M | $47.6M | $22.1M | $26.8M |
| Net debt / EBITDA | โ | โ | โ | โ15.6x | โ40.5x |
| Interest coverage | โ117.0x | โ27.6x | โ17.4x | 0.1x | โ0.1x |
| Current ratio | 1.3x | 1.2x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 0.8x | 0.6x | 0.6x | 0.5x | 0.6x |
| Total assets | $495M | $504M | $435M | $382M | $314M |
| Total liabilities | $362M | $410M | $396M | $330M | $284M |
| Shareholders' equity | โ$27.3M | โ$60.1M | โ$82.1M | โ$88.0M | โ$100M |
| Net debt (โ = net cash) | โ$92.0M | โ$102M | โ$44.4M | โ$41.3M | โ$53.3M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | 3 / 8 | 1 / 8 | 4 / 9 | 2 / 9 | 5 / 9 | 1 / 9 | 7 / 9 | 4 / 9 |
| Accruals ratio | โ | โ5.7% | โ3.4% | 0.7% | โ14.6% | 2.2% | โ10.5% | 2.8% | โ9.7% | โ5.7% |
| Altman Z'' | โ | โ6.83 | 4.32 | โ2.03 | โ0.60 | โ3.15 | โ3.14 | โ4.61 | โ4.09 | โ5.72 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $132M | $142M | $270M | $572M | $1.2B | $1.9B | $2.0B | $2.1B | $2.0B | $1.7B |
| Gross profit | $11.2M | $11.9M | $15.8M | $23.9M | $53.0M | $96.3M | $125M | $120M | $115M | $101M |
| Operating income | โ$54.8M | โ$37.6M | โ$60.5M | โ$71.4M | โ$68.6M | โ$99.6M | โ$55.1M | โ$49.4M | $0.3M | โ$0.3M |
| Interest expense | $0.1M | $0.0M | โ | $0.5M | $1.3M | $0.9M | $2.0M | $2.8M | $3.9M | $4.9M |
| Pretax income | โ$54.7M | โ$36.9M | โ$57.7M | โ$72.6M | โ$67.7M | โ$96.3M | โ$55.9M | โ$49.9M | โ$2.9M | โ$3.1M |
| Income tax | โ | โ | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | โ$54.7M | โ$36.9M | โ$57.7M | โ$72.6M | โ$67.7M | โ$96.3M | โ$55.9M | โ$49.9M | โ$2.9M | โ$3.1M |
| Net income to common | โ$62.9M | โ$36.8M | โ$57.4M | โ$72.3M | โ$66.1M | โ$104M | โ$61.9M | โ$55.4M | โ$9.0M | โ$9.2M |
| Diluted EPS | โ$17.49 | โ$10.21 | โ$11.55 | โ$8.83 | โ$8.03 | โ$12.53 | โ$7.43 | โ$6.58 | โ$1.06 | โ$1.06 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | โ$58.5M | โ$30.2M | โ$51.8M | โ$74.1M | โ$16.9M | โ$107M | โ$3.4M | โ$63.1M | $36.5M | $16.6M |
| Capital expenditure | $0.8M | $1.0M | $2.2M | $2.9M | $3.7M | $9.7M | $4.7M | $1.4M | $2.1M | $0.6M |
| Free cash flow | โ$59.3M | โ$31.2M | โ$54.0M | โ$77.0M | โ$20.6M | โ$117M | โ$8.1M | โ$64.5M | $34.4M | $16.0M |
| Depreciation and amortization | $1.8M | $2.2M | $1.7M | $1.7M | $2.0M | $4.2M | $6.1M | $3.1M | $2.4M | $1.6M |
| Stock-based compensation | $0.5M | $1.5M | $7.8M | $7.9M | $11.0M | $22.6M | $24.1M | $32.0M | $2.8M | $1.4M |
| Share buybacks | โ | โ | โ | $3.3M | $1.7M | $0.9M | โ | โ | โ | โ |
| Dividends and buybacks | โ | โ | โ | $3.3M | $1.7M | $0.9M | โ | โ | โ | โ |
| Balance sheet | ||||||||||
| Cash and short-term investments | $53.8M | $70.9M | $161M | $83.5M | $228M | $133M | $127M | $92.0M | $63.3M | $80.1M |
| Total debt | โ | โ | โ | $13.7M | $35.1M | $40.9M | $25.9M | $47.6M | $22.1M | $26.8M |
| Current assets | โ | $112M | $219M | $213M | $439M | $441M | $469M | $413M | $363M | $304M |
| Current liabilities | โ | $30.9M | $45.7M | $111M | $249M | $335M | $395M | $386M | $321M | $279M |
| Inventory | โ | $22.1M | $30.7M | $69.9M | $117M | $176M | $217M | $200M | $190M | $143M |
| Property and equipment, net | โ | $2.6M | $3.0M | $4.3M | $6.6M | $12.6M | $7.0M | $4.8M | $4.5M | $3.0M |
| Intangible assets | โ | $0.7M | $0.7M | $1.2M | $1.0M | $0.8M | $0.5M | $0.3M | $0.2M | $0.1M |
| Total assets | โ | $117M | $225M | $231M | $463M | $495M | $504M | $435M | $382M | $314M |
| Total liabilities | โ | $30.9M | $46.9M | $120M | $259M | $362M | $410M | $396M | $330M | $284M |
| Shareholders' equity | โ$99.1M | โ$145M | $178M | $112M | $54.7M | โ$27.3M | โ$60.1M | โ$82.1M | โ$88.0M | โ$100M |
| Margins | ||||||||||
| Gross margin | 8.5% | 8.4% | 5.8% | 4.2% | 4.5% | 5.0% | 6.2% | 5.7% | 5.8% | 5.8% |
| Operating margin | โ41.7% | โ26.5% | โ22.4% | โ12.5% | โ5.8% | โ5.2% | โ2.7% | โ2.3% | 0.0% | โ0.0% |
| EBITDA margin | โ40.3% | โ24.9% | โ21.8% | โ12.2% | โ5.6% | โ4.9% | โ2.4% | โ2.2% | 0.1% | 0.1% |
| Net margin | โ41.6% | โ26.0% | โ21.4% | โ12.7% | โ5.7% | โ5.0% | โ2.8% | โ2.4% | โ0.1% | โ0.2% |
| FCF margin | โ45.1% | โ22.0% | โ20.0% | โ13.5% | โ1.7% | โ6.0% | โ0.4% | โ3.1% | 1.7% | 0.9% |
| Returns | ||||||||||
| Return on capital | โ | โ | โ | โ135.2% | โ | โ | โ | โ | โ | โ |
| Return on capital employed | โ | โ43.5% | โ33.8% | โ59.4% | โ32.1% | โ62.3% | โ50.8% | โ102.1% | 0.5% | โ0.9% |
| Return on equity | โ | โ | โ354.1% | โ50.2% | โ81.4% | โ703.3% | โ | โ | โ | โ |
| Return on assets | โ | โ31.4% | โ33.7% | โ31.8% | โ19.5% | โ20.1% | โ11.2% | โ10.6% | โ0.7% | โ0.9% |
| Return on tangible equity | โ | โ | โ32.4% | โ65.5% | โ123.2% | โ | โ | โ | โ | โ |
| Growth | ||||||||||
| Revenue growth | โ | 7.9% | 90.1% | 111.9% | 107.8% | 62.1% | 4.2% | 5.1% | โ5.2% | โ12.7% |
| FCF growth | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ53.7% |
| Share count change | โ | 0.0% | 38.1% | 64.6% | 0.7% | 0.7% | 0.5% | 1.2% | 1.9% | 1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | โ | โ | โ | โ | โ | โ | โ | โ | โ15.6x | โ40.5x |
| Debt / equity | โ | โ | โ | 0.1x | 0.6x | โ | โ | โ | โ | โ |
| Interest coverage | โ485.2x | โ4,640.3x | โ | โ136.3x | โ53.7x | โ117.0x | โ27.6x | โ17.4x | 0.1x | โ0.1x |
| Current ratio | โ | 3.6x | 4.8x | 1.9x | 1.8x | 1.3x | 1.2x | 1.1x | 1.1x | 1.1x |
| Quick ratio | โ | 2.9x | 4.1x | 1.3x | 1.3x | 0.8x | 0.6x | 0.6x | 0.5x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.6% | 0.7% | 0.8% | 0.5% | 0.3% | 0.5% | 0.2% | 0.1% | 0.1% | 0.0% |
| Stock comp / revenue | 0.4% | 1.0% | 2.9% | 1.4% | 0.9% | 1.2% | 1.2% | 1.5% | 0.1% | 0.1% |
| Quality scores | ||||||||||
| Piotroski F-score | โ | โ | 3.0 | 1.0 | 4.0 | 2.0 | 5.0 | 1.0 | 7.0 | 4.0 |
| Altman Z'' | โ | โ6.8 | 4.3 | โ2.0 | โ0.6 | โ3.1 | โ3.1 | โ4.6 | โ4.1 | โ5.7 |
| Accruals ratio | โ | โ5.7% | โ3.4% | 0.7% | โ14.6% | 2.2% | โ10.5% | 2.8% | โ9.7% | โ5.7% |
Source: SEC EDGAR XBRL filings (CIK 0001738906). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 20 ordinary shares). For information only โ not investment advice. Check the original filings before relying on any figure.
